tiprankstipranks
Invion (IVIXD)
OTHER OTC:IVIXD
Holding IVIXD?
Track your performance easily

Invion (IVIXD) Stock News & Sentiment

33 Followers
Invion Begins Promising Skin Cancer Treatment Trial
Premium
Company Announcements
Invion Begins Promising Skin Cancer Treatment Trial
1d ago
Invion (AU:IVX) has released an update. Invion Limited has initiated its Phase I/II trial for a new non-melanoma skin cancer treatment using their innovative drug INV043, which promises effective results ...Read more
Invion Completes Securities Consolidation and Resumes Trading
Premium
Company Announcements
Invion Completes Securities Consolidation and Resumes Trading
6d ago
Invion Limited Expands Share Issuance and Growth Plans
Premium
Company Announcements
Invion Limited Expands Share Issuance and Growth Plans
9d ago

News Score - Last 7 Days

Positive
IVIXD
Sector Average
Media Buzz
This Week5 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average65%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IVIXD’s Media Buzz Sentiment?
5 articles about IVIXD were published this week. In an average week, 1.25 articles are published.
    What is IVIXD’s weekly average amount of articles?
    In an average week, 1.25 articles about IVIXD are published.
      What is IVIXD’s News Sentiment?
      100% of articles about IVIXD were positive this week, compared to its sector average of 65%.
        Healthcare Stocks that are Trending in the News
        CLGNCollplant Holdings
        IVIXDInvion
        SNTISenti Biosciences
        RVMDRevolution Medicines
        NARIInari Medical
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis